OTC labeling meeting postponed

FDA/industry working group meeting scheduled for Nov. 1 postponed to allow more time to review product relabeling sample submissions. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency says. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to noon